Xiang X - Search Results

1

Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.

Xiang X, Jada SR, Li HH, Fan L, Tham LS, Wong CI, Lee SC, Lim R, Zhou QY, Goh BC, Tan EH, Chowbay B. Xiang X, et al. Pharmacogenet Genomics. 2006 Sep;16(9):683-91. doi: 10.1097/01.fpc.0000230420.05221.71. Pharmacogenet Genomics. 2006. PMID: 16906022 Clinical Trial.

2

Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Lal S, Jada SR, Xiang X, Lim WT, Lee EJ, Chowbay B. Lal S, et al. Among authors: xiang x. Clin Pharmacokinet. 2006;45(12):1189-200. doi: 10.2165/00003088-200645120-00004. Clin Pharmacokinet. 2006. PMID: 17112295 Review.

3

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.

Lal S, Wong ZW, Jada SR, Xiang X, Chen Shu X, Ang PC, Figg WD, Lee EJ, Chowbay B. Lal S, et al. Among authors: xiang x. Pharmacogenomics. 2007 Jun;8(6):567-75. doi: 10.2217/14622416.8.6.567. Pharmacogenomics. 2007. PMID: 17559346

4

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.

Lal S, Wong ZW, Sandanaraj E, Xiang X, Ang PC, Lee EJ, Chowbay B. Lal S, et al. Among authors: xiang x. Cancer Sci. 2008 Apr;99(4):816-23. doi: 10.1111/j.1349-7006.2008.00744.x. Cancer Sci. 2008. PMID: 18377430 Free PMC article.

5

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans.

Xiang X, Han Y, Neuvonen M, Pasanen MK, Kalliokoski A, Backman JT, Laitila J, Neuvonen PJ, Niemi M. Xiang X, et al. Pharmacogenet Genomics. 2009 Jun;19(6):447-57. doi: 10.1097/FPC.0b013e32832bcf7b. Pharmacogenet Genomics. 2009. PMID: 19387419

6

VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patients.

Sandanaraj E, Lal S, Cheung YB, Xiang X, Kong MC, Lee LH, Ooi LL, Chowbay B. Sandanaraj E, et al. Among authors: xiang x. Drug Metab Pharmacokinet. 2009;24(4):365-75. doi: 10.2133/dmpk.24.365. Drug Metab Pharmacokinet. 2009. PMID: 19745563 Free article.

7

No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.

Xiang X, Vakkilainen J, Backman JT, Neuvonen PJ, Niemi M. Xiang X, et al. Eur J Clin Pharmacol. 2011 Nov;67(11):1159-67. doi: 10.1007/s00228-011-1070-z. Epub 2011 Jun 8. Eur J Clin Pharmacol. 2011. PMID: 21655991 Clinical Trial.

8

Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings.

Xiang X, Backman JT, Neuvonen PJ, Niemi M. Xiang X, et al. Basic Clin Pharmacol Toxicol. 2012 Mar;110(3):245-52. doi: 10.1111/j.1742-7843.2011.00792.x. Epub 2011 Oct 7. Basic Clin Pharmacol Toxicol. 2012. PMID: 21902813 Free article.

9

A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nimbolide in Mouse Serum: Application to a Preclinical Pharmacokinetics Study.

Wang L, Phan DK, Syn N, Xiang X, Song H, Thuya WL, Yang S, Wong AL, Kumar AP, Yong WP, Sethi G, Ho PC, Goh BC. Wang L, et al. Among authors: xiang x. Pharmaceutics. 2018 Aug 8;10(3):123. doi: 10.3390/pharmaceutics10030123. Pharmaceutics. 2018. PMID: 30096831 Free PMC article.

10

A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs.

Wong AL, Xiang X, Ong PS, Mitchell EQY, Syn N, Wee I, Kumar AP, Yong WP, Sethi G, Goh BC, Ho PC, Wang L. Wong AL, et al. Among authors: xiang x. Pharmaceutics. 2018 Nov 8;10(4):221. doi: 10.3390/pharmaceutics10040221. Pharmaceutics. 2018. PMID: 30413076 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,368 results

Search Page

Filters